Novo Nordisk A/S logo

Novo Nordisk A/S

NONOF | OTC
Chart Builder DCF Calculator
$38.40
+$0.15 (+0.39%)
Sep 24, 2026, 2:55 PM ET · Market open
Fiscal Quarter
Period Ending
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Q4 2020
Dec 30, 2020
Q3 2020
Sep 29, 2020
Q2 2020
Jun 29, 2020
Q1 2020
Mar 30, 2020
Revenue
76.86B 78.09B 85.68B 71.31B 68.06B 65.35B 65.86B 58.73B 54.3B 53.37B 48.09B 45.57B 41.27B 42.03B 38.33B 35.62B 33.04B 33.8B 32.14B 30.93B 30.01B 33.88B
Cost of Revenue
12.85B 12.89B 13.02B 11.31B 10.27B 9.92B 10.01B 9.71B 7.86B 8.18B 8.26B 7.2B 6.07B 6.92B 6.24B 6.06B 5.55B 5.81B 5.62B 5.16B 4.77B 5.39B
Gross Profit
64.01B 65.2B 72.66B 60B 57.79B 55.43B 55.85B 49.02B 46.44B 45.19B 39.83B 38.37B 35.2B 35.11B 32.09B 29.56B 27.49B 27.99B 26.52B 25.77B 25.23B 28.49B
Operating Income
33.45B 38.79B 36.74B 33.82B 25.53B 31.85B 26.77B 26.91B 23.89B 25.01B 8.28B 20.18B 18.39B 19.15B 13.63B 15.25B 14.78B 14.98B 11.18B 12.81B 13.84B 16.3B
Interest Income
5.31B 3.43B -2.65B 1.38B 960M 2.15B n/a 3.32B 647M 852M n/a 1.57B 1.66B 210M n/a 790M 138M 1.75B n/a 162M 97M 17M
Pretax Income
33.81B 37.03B 35.56B 34.38B 25.33B 31.92B 27.62B 28.06B 24.25B 24.74B 16.32B 18.03B 16.8B 17.92B 13.11B 15.11B 14.92B 15.94B 12B 12.69B 13.42B 15.02B
Net Income
26.5B 29.03B 28.23B 27.3B 20.05B 25.41B 21.96B 22.48B 19.43B 19.81B 13.59B 14.41B 13.32B 14.21B 10.89B 12.12B 12.12B 12.62B 9.32B 10.3B 10.63B 11.9B
Selling & General & Admin
18.85B 16.11B 20.28B 16.59B 16.09B 14.41B 18.63B 14.08B 15.41B 13.48B 15.09B 12.61B 11.83B 11.15B 12.82B 10.14B 8.91B 9.19B 10.96B 9.18B 8.23B 8.52B
Research & Development
11.69B 10.31B 13.8B 9.49B 16.17B 8.61B 10.46B 8.13B 7.13B 6.73B 8.09B 5.63B 5.12B 5.21B 5.63B 4.25B 3.94B 3.94B 4.48B 3.91B 3.29B 3.78B
Other Expenses
23M -14M 1.84B 101M n/a 568M -3M -98M 15M -33M -433M -60M -149M -392M 4M -81M -134M -121M -106M -127M -120M -107M
Operating Expenses
30.56B 26.41B 35.92B 26.18B 32.26B 23.59B 29.08B 22.11B 22.56B 20.18B 22.74B 18.18B 16.81B 15.97B 18.46B 14.31B 12.72B 13.01B 15.34B 12.96B 11.4B 12.19B
Interest Expense
4.96B 5.18B -2.82B 821M 1.56B 2.07B n/a 2.17B 281M 1.12B n/a 3.73B 3.25B 1.44B n/a 927M n/a 797M 53M 279M 519M 1.3B
Selling & Marketing Expenses
17.53B 14.89B 18.7B 15.21B 14.93B 13.26B 17.17B 12.82B 14.34B 12.41B 13.74B 11.45B 10.84B 10.18B 11.63B 9.12B 8B 8.26B 9.77B 8.17B 7.4B 7.59B
Cost & Expenses
43.41B 39.3B 48.95B 37.39B 42.53B 32.94B 39.1B 31.82B 30.41B 28.36B 31.01B 25.38B 22.87B 22.88B 24.7B 20.37B 18.26B 18.82B 20.96B 18.12B 16.17B 17.57B
Income Tax Expense
7.3B 8B 7.33B 7.08B 5.28B 6.51B 5.66B 5.59B 4.83B 4.92B 2.72B 3.63B 3.48B 3.71B 2.22B 2.99B 2.79B 3.32B 2.68B 2.39B 2.79B 3.12B
Shares Outstanding (Basic)
4.45B 4.44B 4.45B 4.45B 4.46B 4.46B 4.46B 4.5B 4.49B 4.5B 4.51B 4.52B 4.54B 4.55B 4.58B 4.59B 4.61B 4.63B 4.65B 4.66B 4.69B 4.71B
Shares Outstanding (Diluted)
4.45B 4.45B 4.46B 4.46B 4.47B 4.47B 4.48B 4.49B 4.5B 4.51B 4.52B 4.54B 4.55B 4.57B 4.58B 4.6B 4.61B 4.63B 4.65B 4.67B 4.69B 4.71B
EPS (Basic)
5.96 6.54 6.34 6.13 4.50 5.70 4.92 5.02 4.33 8.81 6.01 3.17 2.93 3.11 4.75 5.29 5.26 5.47 4 4.42 4.54 5.07
EPS (Diluted)
5.96 6.53 6.33 6.12 4.49 5.68 4.91 5 4.32 8.78 5.99 3.18 2.93 3.11 4.75 5.27 5.26 5.45 4 4.42 4.53 5.05
EBITDA
43.6B 46.05B 40.14B 37.36B 35.74B 35.33B 30.61B 29.44B 26.71B 27.58B 19.12B 23.8B 21.68B 21.01B 15.97B 17.39B 16B 18.11B 13.91B 15.1B 15.09B 17.41B
EBIT
38.76B 42.22B 34.94B 35.21B 26.89B 31.85B 25.52B 26.91B 24.54B 25.01B 17.09B 20.18B 18.39B 19.15B 11.73B 15.25B 14.78B 14.98B 10.3B 12.81B 13.84B 16.3B
Depreciation & Amortization
4.83B 3.83B 5.2B 2.15B 8.85B 2.91B 2.99B 2.53B 2.18B 1.72B 2.04B 2.04B 1.64B 1.65B 2.08B 1.35B 1.22B 1.38B 1.38B 2.13B 1.16B 1.09B

© 2026 bestshares.com. All rights reserved.